
Short Title: EA8191 (INDICATE)
Enrollment Status: Recruiting
NCT #: NCT04423211
Specialty Area: Oncology
Condition Studied: Prostatic Adenocarcinoma
Age Groups: Adult; Older Adult
Phase: III
The purpose of this study is to compare the usual treatment alone to the usual treatment plus additional treatment for patients with prostatic adenocarcinoma, based on the results of PET imaging that looks for cancer that has spread outside of the pelvis.
All participants in this study have had their prostate removed (a radical prostatectomy) and have a rising PSA blood level afterward, which is called biochemical recurrence. A PSMA PET scan is used to look for areas of cancer, and the results of that scan help guide which treatment options are studied.
If the PET scan finds areas of tumor outside of the pelvis (for example, metastases, or metastatic lesions), this study will look at whether treating those areas with targeted, metastasis-directed radiation affects cancer control.
This study is open to adult and older adult men who have a rising PSA level after surgery to remove the prostate. The points below describe the main eligibility requirements. They are not the complete list.
Healthy volunteers are not enrolled in this study. The study team can review the full list of eligibility requirements with you, and the complete criteria are also listed on ClinicalTrials.gov under study NCT04423211.
Participation in this study includes imaging, assignment to a treatment option by chance (randomization), treatment, and follow-up visits with regular monitoring. What this involves may include:
Participants also return for follow-up visits that may include physical exams, blood tests such as PSA, and imaging. The study team will explain the schedule of visits and procedures before you decide whether to take part.
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT04423211
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.